Literature DB >> 11406768

A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob.

H Mizuguchi1, N Koizumi, T Hosono, N Utoguchi, Y Watanabe, M A Kay, T Hayakawa.   

Abstract

The use of recombinant adenovirus (Ad) vectors containing genetically modified capsid proteins is an attractive strategy for achieving targeted gene transfer. The HI loop of the fiber knob is a promising candidate location for the incorporation of foreign ligands for achieving this goal. However, the method of constructing an Ad vector containing a foreign ligand in the HI loop of the fiber knob has proved difficult. In this study, we developed a simple system to construct fiber-modified vectors. To do this, a vector plasmid containing a complete E1/E3-deleted Ad type 5 genome and a unique Csp45I and/or ClaI site between positions 32679 and 32680 of the Ad genome (residues threonine-546 and proline-547 of the fiber protein) was constructed. Oligonucleotides corresponding to the Arg-Gly-Asp (RGD) or Asn-Gly-Arg (NGR)-containing peptide motif (as a model) and containing a Csp45I and/or ClaI recognition site, were ligated into the Csp45I and/or ClaI-digested plasmid. The foreign transgene expression cassette was inserted into the E1 deletion site of the vector plasmid and the fiber-mutant Ad vector was produced by transfection of the PacI-digested plasmid into 293 cells. The virus containing the RGD or NGR peptide on the fiber knob was able to infect human glioma cells, which do not express coxsackievirus and adenovirus receptor (CAR), one of the Ad virus receptors, about 100-1000 times more efficient than the virus containing wild-type fiber. This suggested that the mutant virus mediated CAR-independent cell entry pathway. The simplicity of this method allows not only for easy construction of fiber-mutant Ad vectors, but also for screening of the peptides that target the vector to the desired cells and tissues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11406768     DOI: 10.1038/sj.gt.3301453

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  36 in total

1.  Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.

Authors:  Naoya Koizumi; Hiroyuki Mizuguchi; Fuminori Sakurai; Teruhide Yamaguchi; Yoshiteru Watanabe; Takao Hayakawa
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein.

Authors:  Natalya Belousova; Valentina Krendelchtchikova; David T Curiel; Victor Krasnykh
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

3.  Efficient Gene Transduction of Dispersed Islet Cells in Culture Using Fiber-Modified Adenoviral Vectors.

Authors:  Hiroyuki Hanayama; Kazuo Ohashi; Rie Utoh; Hirofumi Shimizu; Kazuya Ise; Fuminori Sakurai; Hiroyuki Mizuguchi; Hiroyuki Tsuchiya; Teruo Okano; Mitsukazu Gotoh
Journal:  Cell Med       Date:  2015-08-26

Review 4.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

Review 5.  Current strategies and future directions for eluding adenoviral vector immunity.

Authors:  Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Gene Ther       Date:  2006-04       Impact factor: 4.391

6.  Expression of HIF-1α ODD domain fused canine caspase 3 by EGFR promoter-driven adenovirus vector induces cytotoxicity in canine breast tumor cells under hypoxia.

Authors:  Mariko Okamoto; Ai Asamura; Ko Tanaka; Takefumi Soeda; Kyo Watanabe; Hiroyuki Mizuguchi; Teruo Ikeda
Journal:  Vet Res Commun       Date:  2016-10-16       Impact factor: 2.459

7.  Particle tracking of intracellular trafficking of octaarginine-modified liposomes: a comparative study with adenovirus.

Authors:  Hidetaka Akita; Kaoru Enoto; Tomoya Masuda; Hiroyuki Mizuguchi; Tomomi Tani; Hideyoshi Harashima
Journal:  Mol Ther       Date:  2010-03-09       Impact factor: 11.454

8.  RGD-IL-24, a novel tumor-targeted fusion cytokine: expression, purification and functional evaluation.

Authors:  Bin Xiao; Wei Li; Jun Yang; Gang Guo; Xu-Hu Mao; Quan-Ming Zou
Journal:  Mol Biotechnol       Date:  2008-10-25       Impact factor: 2.695

9.  Ex-vivo evaluation of gene therapy vectors in human pancreatic (cancer) tissue slices.

Authors:  Michael-A van Geer; Koert F D Kuhlmann; Conny T Bakker; Fibo J W ten Kate; Ronald P J Oude Elferink; Piter J Bosma
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

10.  Intratracheal delivery of CX3CL1-expressing mesenchymal stem cells to multiple lung tumors.

Authors:  Hong Xin; Ruowen Sun; Masahiko Kanehira; Takenori Takahata; Jugoh Itoh; Hiroyuki Mizuguchi; Yasuo Saijo
Journal:  Mol Med       Date:  2009-06-18       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.